Kymera Therapeutics (KYMR) 8-K Summary

Kymera Therapeutics, Inc. filed this Form 8-K on November 4, 2025, to announce its financial results for the quarter ended September 30, 2025.

• Key Event: Release of Q3 2025 earnings information.
• Details Location: Full financial performance metrics are provided in Exhibit 99.1 (the furnished press release).
• Regulatory Note: Information furnished via this 8-K is generally not considered “filed” under Section 18 of the Exchange Act.

Investors should review Exhibit 99.1 for specific financial performance, guidance, or materi